Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03229759Phase 2Completed
A Phase 2 trial of octenidine in surgical site infection (SSI), sponsored by BD. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03229759.